Mark Ashton

679 total citations
15 papers, 289 citations indexed

About

Mark Ashton is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark Ashton has authored 15 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Computational Theory and Mathematics and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark Ashton's work include Computational Drug Discovery Methods (3 papers), Insect and Pesticide Research (2 papers) and Chemical Synthesis and Analysis (1 paper). Mark Ashton is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Insect and Pesticide Research (2 papers) and Chemical Synthesis and Analysis (1 paper). Mark Ashton collaborates with scholars based in United Kingdom, United States and Australia. Mark Ashton's co-authors include D. J. BAYSTON, Anthony D. Baxter, M. E. C. POLYWKA, Geoffrey M. Downs, John M. Barnard, Alain‐Dominique Gorse, M. Charlton, Florence Casset, Peter Willett and Roger Lahana and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and The American Historical Review.

In The Last Decade

Mark Ashton

13 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Ashton United Kingdom	7	118	91	83	61	51	15	289
Miguel A. Maria‐Solano Spain	11	436 3.7×	56 0.6×	25 0.3×	46 0.8×	106 2.1×	14	546
Malcolm J. Kavarana United States	11	262 2.2×	53 0.6×	27 0.3×	29 0.5×	47 0.9×	14	452
János Éles Hungary	11	92 0.8×	150 1.6×	33 0.4×	13 0.2×	32 0.6×	34	342
Sunil K. Pandey India	11	203 1.7×	153 1.7×	34 0.4×	12 0.2×	67 1.3×	15	394
Fredrik Rahm Sweden	10	83 0.7×	192 2.1×	56 0.7×	45 0.7×	13 0.3×	15	303
Daniel G. Shore Canada	9	93 0.8×	346 3.8×	43 0.5×	21 0.3×	9 0.2×	10	435
Tuan P. Tran United States	11	176 1.5×	183 2.0×	42 0.5×	41 0.7×	9 0.2×	14	337
Fukang Yang United States	9	74 0.6×	112 1.2×	14 0.2×	32 0.5×	16 0.3×	22	246
Sonja Nordhoff Germany	9	114 1.0×	51 0.6×	13 0.2×	30 0.5×	81 1.6×	11	323
Laurie B. Schenkel United States	13	125 1.1×	390 4.3×	99 1.2×	6 0.1×	13 0.3×	24	582

Countries citing papers authored by Mark Ashton

Since Specialization

Citations

This map shows the geographic impact of Mark Ashton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ashton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ashton more than expected).

Fields of papers citing papers by Mark Ashton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ashton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ashton. The network helps show where Mark Ashton may publish in the future.

Co-authorship network of co-authors of Mark Ashton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ashton. A scholar is included among the top collaborators of Mark Ashton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ashton. Mark Ashton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kapralov, Maxim V., et al.. (2024). Plant‐derived compounds as potential leads for new drug development targeting COVID‐19. Phytotherapy Research. 38(3). 1522–1554. 1 indexed citations

Ashton, Mark, et al.. (2020). The development of a predictive model to identify potential HIV-1 attachment inhibitors. Computers in Biology and Medicine. 120. 103743–103743. 2 indexed citations

Azimi, Iman, Ralph J. Stevenson, Xuexin Zhang, et al.. (2020). A New Selective Pharmacological Enhancer of the Orai1 Ca²⁺ Channel Reveals Roles for Orai1 in Smooth and Skeletal Muscle Functions. ACS Pharmacology & Translational Science. 3(1). 135–147. 25 indexed citations

McGarry, Kenneth, David E. Nelson, & Mark Ashton. (2020). A Method to Explore the Connectivity Patterns of Proteins and Drugs for Identifying Disease Communities. SN Computer Science. 1(3). 1 indexed citations

Ashton, Mark & Adam Todd. (2011). Current research and development of new treatments for schizophrenia. Durham Research Online (Durham University).

Sherwood, J. Timothy, et al.. (2011). Current and future options for the management of heart failure. Sunderland Repository (University of Sunderland). 1 indexed citations

Todd, Adam, et al.. (2010). Current research and development of treatments for Alzheimer’s disease. Durham Research Online (Durham University). 1 indexed citations

Duff, Stephen M. G., Y. Gopichand, Bruce C. Hamper, et al.. (2006). The carboxyterminal processing protease of D1 protein: Herbicidal activity of novel inhibitors of the recombinant and native spinach enzymes. Pesticide Biochemistry and Physiology. 88(1). 1–13. 9 indexed citations

Armer, Richard, Mark Ashton, Frederick A. Brookfield, et al.. (2005). Indole-3-acetic Acid Antagonists of the Prostaglandin D₂ Receptor CRTH2. Journal of Medicinal Chemistry. 48(20). 6174–6177. 39 indexed citations

10.

Ashton, Mark, Michael Charlton, Matthias Schwarz, Russell J. Thomas, & Mark Whittaker. (2004). The Selection and Design of GPCR Ligands: From Concept to the Clinic. Combinatorial Chemistry & High Throughput Screening. 7(5). 441–452. 10 indexed citations

11.

Ashton, Mark, John M. Barnard, Florence Casset, et al.. (2002). Identification of Diverse Database Subsets using Property‐Based and Fragment‐Based Molecular Descriptions. Quantitative Structure-Activity Relationships. 21(6). 598–604. 67 indexed citations

12.

BAYSTON, D. J., et al.. (1998). Preparation and Use of a Polymer Supported BINAP Hydrogenation Catalyst. The Journal of Organic Chemistry. 63(9). 3137–3140. 114 indexed citations

13.

Ranum, Orest, et al.. (1995). The Utility of Splendor: Ceremony, Social Life, and Architecture at the Court of Bavaria, 1600-1800.. The American Historical Review. 100(5). 1601–1601. 3 indexed citations

14.

Ashton, Mark, et al.. (1995). Total synthesis of modified jstx toxins: reductive alkylation is a practical route to hexahydropyrimidine polyamine amides. Tetrahedron Letters. 36(51). 9397–9400. 14 indexed citations

15.

Ashton, Mark. (1978). Allegory, Fact, and Meaning in Giambattista Tiepolo's Four Continents in Würzburg. The Art Bulletin. 60(1). 109–125. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact